Hemodialysis Prescription for Incident Patients: Twice Seems Nice, But Is It Incremental?

American Journal of Kidney Diseases

Volumn 68, Issue 2, 2016, Pages 180-183

  Toth Manikowski, Stephanie M ^a,b   Shafi, Tariq ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CYSTATIN C; IOHEXOL; TRACE PROTEIN; UNCLASSIFIED DRUG; UREA;

COST CONTROL; EDITORIAL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SURVIVAL; URINALYSIS; URINE SAMPLING; URINE VOLUME; CHRONIC KIDNEY FAILURE;

HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84990212045     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.04.005     Document Type: Editorial

References (42)

1. 1 Saran, R., Li, Y., Robinson, B., et al. US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 67:3 suppl 1 (2016), S1–S434.
2. 2 Foley, R.N., Gilbertson, D.T., Murray, T., Collins, A.J., Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365:12 (2011), 1099–1107.
3. 3 Fotheringham, J., Fogarty, D.G., El Nahas, M., Campbell, M.J., Farrington, K., The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney Int 88:3 (2015), 569–575.
4. 4 Meyer, T.W., Sirich, T.L., Hostetter, T.H., Dialysis cannot be dosed. Semin Dial 24:5 (2011), 471–479.
5. 5 Tenckhoff H. Peripheral neuropathy complicating chronic dialysis. Proceedings of the Working Conference Chronic Dialysis; Seattle, WA; 1964. Seattle, WA: University of Washington Press; 1965:120-123.
6. 6 Scribner, B.H., Cole, J.J., Ahmad, S., Blagg, C.R., Why thrice weekly dialysis?. Hemodial Int 8:2 (2004), 188–192.
7. 7 Gotch, F.A., Sargent, J.A., A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:3 (1985), 526–534.
8. 8 Lowrie, E.G., Laird, N.M., Parker, T.F., Sargent, J.A., Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:20 (1981), 1176–1181.
9. 9 Eknoyan, G., Beck, G.J., Cheung, A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:25 (2002), 2010–2019.
10. 10 Daugirdas, J.T., Greene, T., Rocco, M.V., et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:5 (2013), 949–958.
11. 11 Golper, T.A., Mehrotra, R., The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:10 (2015), 1602–1604.
12. 12 Shafi, T., Jaar, B.G., Plantinga, L.C., et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:2 (2010), 348–358.
13. 13 van der Wal, W.M., Noordzij, M., Dekker, F.W., et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:9 (2011), 2978–2983.
14. 14 Marquez, I.O., Tambra, S., Luo, F.Y., et al. Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:2 (2011), 290–296.
15. 15 Vilar, E., Wellsted, D., Chandna, S.M., Greenwood, R.N., Farrington, K., Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:8 (2009), 2502–2510.
16. 16 Menon, M.K., Naimark, D.M., Bargman, J.M., Vas, S.I., Oreopoulos, D.G., Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:11 (2001), 2207–2213.
17. 17 Wang, A.Y., Wang, M., Woo, J., et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:2 (2002), 639–647.
18. 18 Wong, J., Vilar, E., Davenport, A., Farrington, K., Incremental haemodialysis. Nephrol Dial Transplant 30:10 (2015), 1639–1648.
19. 19 National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66:5 (2015), 884–930.
20. 20 Section II. Haemodialysis adequacy. Nephrol Dial Transplant 17:suppl 7 (2002), 16–31.
21. 21 Obi, Y., Streja, E., Rhee, C.M., et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:2 (2016), 256–265.
22. 22 Chauhan, R., Mendonca, S., Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre. Indian J Nephrol 25:6 (2015), 329–333.
23. 23 Zhang, M., Wang, M., Li, H., et al. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40:2 (2014), 140–150.
24. 24 Panaput, T., Thinkhamrop, B., Domrongkitchaiporn, S., et al. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif 38:3-4 (2014), 253–262.
25. 25 Lei, G., Li, X., Tu, W., Xu, C., Duan, Z., Wu, X., Risk of intradialytic hypotension in patients on thrice-weekly versus twice-weekly hemodialysis. Int J Cardiol 174:3 (2014), 821–823.
26. 26 Cheng, Y., Tu, W., Xiao, Q., Chen, Y., Hu, L., Wu, X., Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis. Int J Cardiol 174:3 (2014), 780–783.
27. 27 Bieber, B., Qian, J., Anand, S., et al. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and quality of life in the China Dialysis Outcomes and Practice Patterns study. Nephrol Dial Transplant 29:9 (2014), 1770–1777.
28. 28 Bello, B.T., Raji, Y.R., Sanusi, I., Braimoh, R.W., Amira, O.C., Mabayoje, O.M., Challenges of providing maintenance hemodialysis in a resource poor country: experience from a single teaching hospital in Lagos, Southwest Nigeria. Hemodial Int 17:3 (2013), 427–433.
29. 29 Lin, X., Yan, Y., Ni, Z., et al. Clinical outcome of twice-weekly hemodialysis patients in Shanghai. Blood Purif 33:1-3 (2012), 66–72.
30. 30 Stankuviene, A., Ziginskiene, E., Kuzminskis, V., Bumblyte, I.A., Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005. Medicina (Kaunas) 46:8 (2010), 516–521.
31. 31 Supasyndh, O., Satirapoj, B., Seenamngoen, S., Yongsiri, S., Choovichian, P., Vanichakarn, S., Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. J Med Assoc Thai 92:5 (2009), 624–631.
32. 32 Lin, Y.F., Huang, J.W., Wu, M.S., et al. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14:1 (2009), 59–64.
33. 33 Tzamaloukas, A.H., Vanderjagt, D.J., Agaba, E.I., et al. Inadequacy of dialysis, chronic inflammation and malnutrition in Nigerian patients on chronic hemodialysis. Int J Artif Organs 29:11 (2006), 1067–1073.
34. 34 Fernandez-Lucas, M., Teruel-Briones, J.L., Gomis-Couto, A., Villacorta-Perez, J., Quereda-Rodriguez-Navarro, C., Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 32:6 (2012), 767–776.
35. 35 Casino, F.G., Lopez, T., The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:8 (1996), 1574–1581.
36. 36 Gotch, F.A., The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13:suppl 6 (1998), 10–14.
37. urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int 77:7 (2010), 637–644.
38. 38 Keshaviah, P.R., Emerson, P.F., Nolph, K.D., Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 33:2 (1999), 344–348.
39. 39 Shafi, T., Levey, A.S., Inker, L.A., et al. Plasma iohexol clearance for assessing residual kidney function in dialysis patients. Am J Kidney Dis 66:4 (2015), 728–730.
40. 40 Shafi, T., Michels, W.M., Levey, A.S., et al. Estimating residual kidney function in dialysis patients without urine collection. Kidney Int 89:5 (2016), 1099–1110.
41. 41 Vanholder, R., Van Biesen, W., Lameire, N., Is starting hemodialysis on a twice-weekly regimen a valid option?. Am J Kidney Dis 64:2 (2014), 165–167.
42. 42 Agarwal, R., Volume overload in dialysis: the elephant in the room, no one can see. Am J Nephrol 38:1 (2013), 75–77.